Major factors shaping the Dermal Filler Market|Key Players: Allergan Biologics Ltd., Merz Pharma, Syneron Candela, Cynosure, Inc.

The Dermal Filler Market is set to exceed USD 8.5 billion by 2024; according to a new research report by Global Market Insights. Rising awareness and acceptance regarding several cosmetic procedures in developed and developing regions coupled with increasing disposable income will impel dermal filler market size. Demand for dermal filler injections dramatically increased during recent years among high income Saudi Arabian women. Moreover, rising awareness about superior benefits coupled with minimal pain involved with the procedure will drive global dermal filler market growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3032

With increasing preference for minimally invasive and non-invasive procedures, dermal filler business will witness considerable increase in its revenue size. As per data based on a clinical center in the U.S., the demand for surgical facelifts declined as several surgeons started offering non-invasive facelifts, called mini-lifts using dermal fillers in the country. Additionally, these soft tissue fillers offer quick, affordable and durable treatment that should offer lucrative dermal filler market growth potential over the coming years.

Increasing obsession about physical appearance, rising disposable income and growing awareness about facial aesthetics will drive dermal filler market over the forecast timeframe. Shift in preference from invasive to non-invasive surgical procedures should accelerate industry growth. According to The International Society of Aesthetic Plastic Surgery (ISAPS), the number of non-surgical cosmetic procedures has increased by around 9% annually in 2017. Cost-effectiveness offered in some countries such as China, India for dermal filler therapy will support regional dermal filler market growth.

Biodegradable fillers segment held largest market share of around 88% in 2017 due to safety offered by this type of fillers. Complications related with the use of dermal fillers disappears spontaneously as biodegradable substances are eventually metabolized by the body. Juvederm XC, a hyaluronic acid developed by Allergan is commonly used to reduce facial lines. Industry players are increasingly investing into development of biodegradable fillers that removes necessity of allergy testing.

Growing demand for enhancement of cosmetic value for shorter timeframe has escalated demand for temporary biodegradable dermal fillers. Temporary biodegradable dermal fillers segment is estimated to grow by 6.2% during the forecast period. This type of dermal fillers last less than year, hence it is frequently adopted by patients wanting to experiment with soft tissue augmentation, but do not want new look for prolonged time.

Hyaluronic acid segment accounted over USD 4.5 billion in 2017. Hyaluronic acid is associated with dehydration and wrinkling of skin. It is commonly adopted by elderly people to correct facial lines and reduce wrinkling. After Botox, hyaluronic acid is most commonly performed non-surgical cosmetic procedure in the U.S. Large number of approved products, lower risk of complications and growing adoption should accelerate segment growth during the forecast period.

Autologous fat segment is estimated to experience robust growth of 8.9% during the forecast period. Less invasiveness is major driving factor for the segment growth. Moreover, applications of fat dermal filler including treatment of facial scars, nasolabial folds, forehead and temporal augmentation should escalate its adoption rate over the coming years.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3032

U.S. dermal filler market dominated North America Dermal Filler market in 2017 and is anticipated to experience 5.8% CAGR during the forecast period. Growing adoption of facial aesthetic procedures, shift in preference from invasive to non-invasive procedures coupled with rising awareness about soft tissue fillers will drive U.S. dermal filler market. Availability with numerous products in market with frequent introduction of innovative products should positively impact industry growth.

Australia dermal filler market will foresee remarkable progress at 8.2% CAGR throughout the forecast timeframe. Increasing spending on non-invasive beauty treatments especially among baby boomers will highly impact dermal filler business growth. As per data from The Cosmetic Physicians Society of Australasia, demand for dermal fillers significantly increased during 2014 and is estimated to rise over the coming years. Thus, growing elderly population and presence of established players such as Allergan should augment Australia dermal filler market growth over the upcoming period.

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.